151 related articles for article (PubMed ID: 30063915)
1. Matrine blocks AGEs- induced HCSMCs phenotypic conversion via suppressing Dll4-Notch pathway.
Liu Z; Wang Y; Zhu H; Qiu C; Guan G; Wang J; Guo Y
Eur J Pharmacol; 2018 Sep; 835():126-131. PubMed ID: 30063915
[TBL] [Abstract][Full Text] [Related]
2. Matrine suppresses advanced glycation end products-induced human coronary smooth muscle cells phenotype conversion by regulating endoplasmic reticulum stress-dependent Notch signaling.
Zhao L; Cai H; Tang Z; Cui Q; Liu Z; Lu S
Eur J Pharmacol; 2020 Sep; 882():173257. PubMed ID: 32540158
[TBL] [Abstract][Full Text] [Related]
3. Matrine pre-treatment suppresses AGEs- induced HCSMCs fibrotic responses by regulating Poldip2/mTOR pathway.
Ma W; Xu J; Zhang Y; Zhang H; Zhang Z; Zhou L; Wang X; Liu H; Chen Y; Du P; Min N; Liu Z; Yin Y
Eur J Pharmacol; 2019 Dec; 865():172746. PubMed ID: 31634459
[TBL] [Abstract][Full Text] [Related]
4. Matrine inhibits advanced glycation end products-induced macrophage M1 polarization by reducing DNMT3a/b-mediated DNA methylation of GPX1 promoter.
Cui Q; Du H; Ma Y; Wang T; Zhu H; Zhu L; Pan S; Min N; Wang X; Liu Z
Eur J Pharmacol; 2022 Jul; 926():175039. PubMed ID: 35597264
[TBL] [Abstract][Full Text] [Related]
5. Matrine suppresses AGE-induced HAEC injury by inhibiting ROS-mediated NRLP3 inflammasome activation.
Zhang Y; Yang X; Qiu C; Liu F; Liu P; Liu Z
Eur J Pharmacol; 2018 Mar; 822():207-211. PubMed ID: 29374549
[TBL] [Abstract][Full Text] [Related]
6. Matrine attenuates cardiac fibrosis by affecting ATF6 signaling pathway in diabetic cardiomyopathy.
Liu Z; Zhang Y; Tang Z; Xu J; Ma M; Pan S; Qiu C; Guan G; Wang J
Eur J Pharmacol; 2017 Jun; 804():21-30. PubMed ID: 28373137
[TBL] [Abstract][Full Text] [Related]
7. Regulation of vascular smooth muscle cell phenotype in three-dimensional coculture system by Jagged1-selective Notch3 signaling.
Bhattacharyya A; Lin S; Sandig M; Mequanint K
Tissue Eng Part A; 2014 Apr; 20(7-8):1175-87. PubMed ID: 24138322
[TBL] [Abstract][Full Text] [Related]
8. Matrine induces the hepatic differentiation of WB-F344 rat hepatic progenitor cells and inhibits Jagged 1/HES1 signaling.
Yang Z; Wang L; Wang X
Mol Med Rep; 2016 Oct; 14(4):3841-7. PubMed ID: 27573552
[TBL] [Abstract][Full Text] [Related]
9. Notch signaling triggered via the ligand DLL4 impedes M2 macrophage differentiation and promotes their apoptosis.
Pagie S; Gérard N; Charreau B
Cell Commun Signal; 2018 Jan; 16(1):4. PubMed ID: 29321062
[TBL] [Abstract][Full Text] [Related]
10. Matrine alleviates AGEs- induced cardiac dysfunctions by attenuating calcium overload via reducing ryanodine receptor 2 activity.
Wang J; Tang Z; Zhang Y; Qiu C; Zhu L; Zhao N; Liu Z
Eur J Pharmacol; 2019 Jan; 842():118-124. PubMed ID: 30339815
[TBL] [Abstract][Full Text] [Related]
11. Novel ASK1 Inhibitor AGI-1067 Attenuates AGE-Induced Fibrotic Response by Suppressing the MKKs/p38 MAPK Pathway in Human Coronary Arterial Smooth Muscle Cells.
Liu Z; Shi S; Zhu H; Chen Y; Zhang Y; Zheng Z; Wang X
Int Heart J; 2018 Nov; 59(6):1416-1424. PubMed ID: 30305582
[TBL] [Abstract][Full Text] [Related]
12. Advanced Glycation End Products Induce Atherosclerosis via RAGE/TLR4 Signaling Mediated-M1 Macrophage Polarization-Dependent Vascular Smooth Muscle Cell Phenotypic Conversion.
Xing Y; Pan S; Zhu L; Cui Q; Tang Z; Liu Z; Liu F
Oxid Med Cell Longev; 2022; 2022():9763377. PubMed ID: 35069982
[TBL] [Abstract][Full Text] [Related]
13. Notch signaling regulates arterial vasoreactivity through opposing functions of Jagged1 and Dll4 in the vessel wall.
Basu S; Barbur I; Calderon A; Banerjee S; Proweller A
Am J Physiol Heart Circ Physiol; 2018 Dec; 315(6):H1835-H1850. PubMed ID: 30168730
[TBL] [Abstract][Full Text] [Related]
14. Matrine inhibits disturbed flow-enhanced migration via downregulation of ERK1/2-MLCK signaling vascular smooth muscle cells.
Zhu P; Chen JM; Guo HM; Fan XP; Zhang XS; Fan RX; Zheng SY; Wu RB; Xiao XJ; Huang HL; Zhu XL; Liu HP; Long G; Chen YF; Zhuang J
Ann Vasc Surg; 2012 Feb; 26(2):268-75. PubMed ID: 22304864
[TBL] [Abstract][Full Text] [Related]
15. Matrine promotes hepatic oval cells differentiation into hepatocytes and alleviates liver injury by suppression of Notch signalling pathway.
Shi J; Han G; Wang J; Han X; Zhao M; Duan X; Mi L; Li N; Yin X; Shi H; Li C; Xu J; Yin F
Life Sci; 2020 Nov; 261():118354. PubMed ID: 32866517
[TBL] [Abstract][Full Text] [Related]
16. Matrine suppresses cardiac fibrosis by inhibiting the TGF‑β/Smad pathway in experimental diabetic cardiomyopathy.
Zhang Y; Cui L; Guan G; Wang J; Qiu C; Yang T; Guo Y; Liu Z
Mol Med Rep; 2018 Jan; 17(1):1775-1781. PubMed ID: 29138820
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of beta-catenin.
Zhang J; Fukuhara S; Sako K; Takenouchi T; Kitani H; Kume T; Koh GY; Mochizuki N
J Biol Chem; 2011 Mar; 286(10):8055-8066. PubMed ID: 21212269
[TBL] [Abstract][Full Text] [Related]
18. Matrine-Type Alkaloids Inhibit Advanced Glycation End Products Induced Reactive Oxygen Species-Mediated Apoptosis of Aortic Endothelial Cells In Vivo and In Vitro by Targeting MKK3 and p38MAPK Signaling.
Liu Z; Lv Y; Zhang Y; Liu F; Zhu L; Pan S; Qiu C; Guo Y; Yang T; Wang J
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29197828
[TBL] [Abstract][Full Text] [Related]
19. Matrine inhibits vascular smooth muscle cell proliferation by modulating the expression of cell cycle regulatory genes.
Zhu P; Chen JM; Chen SZ; Zhang C; Zheng SY; Long G; Chen J; Zhou ZL; Fan RX; Fan XP; Chen YF; Zhuang J
Acta Pharmacol Sin; 2010 Oct; 31(10):1329-35. PubMed ID: 20835268
[TBL] [Abstract][Full Text] [Related]
20. Matrine inhibits the expression of adhesion molecules in activated vascular smooth muscle cells.
Liu J; Zhang L; Ren Y; Gao Y; Kang L; Lu S
Mol Med Rep; 2016 Mar; 13(3):2313-9. PubMed ID: 26783147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
